Ofer Gonen is the founder of MediWound. MediWound has raised $200M in total funding. Latest round: Growth. Based in Yavne, Israel.
Ofer Gonen was appointed CEO of MediWound on June 30, 2022. MediWound is a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration. Prior to this role, Gonen served as a board member of MediWound and as CEO of Clal Biotechnology Industries Ltd., MediWound's largest shareholder, for five years.
Full founder directory · Investor directory · Company funding database · Fundraising library